Samalin Investment Counsel, LLC Edwards Lifesciences Corp Transaction History

Samalin Investment Counsel, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $3,373 - $5,002	-39 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$83.84 - $104.76 $3,269 - $4,085	39 New	39 $4,000
Q1 2021 May 11, 2021	SELL	$78.68 - $90.67 $6,609 - $7,616	-84 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$67.19 - $87.44 $5,643 - $7,344	84 New	84 $6,000
Q1 2020 May 04, 2020	SELL	$52.41 - $81.0 $681 - $1,053	-13 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$71.7 - $82.09 $932 - $1,067	13 New	13 $3,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.